Page 1628 - Saunders Comprehensive Review For NCLEX-RN
P. 1628

hypersensitivity or with acute liver
                                                                disease
                                                             b. Use with caution in clients with chronic
                                                                liver disease, alcoholism, or renal
                                                                impairment.
                                                             c. Use with caution in clients taking
                                                                nicotinic acid.
                                                             d. Use with caution in clients taking
                                                                hepatotoxic medications because the
                                                                risk for hepatotoxicity increases.
                                                             e. Alcohol increases the risk of
                                                                hepatotoxicity.
                                                             f. May increase the risk of toxicity of
                                                                carbamazepine and phenytoin
                                                             g. May decrease ketoconazole
                                                                concentrations
                                             3. Side and adverse effects
                                                             a. Hypersensitivity reactions

                                                             b.        Peripheral neuritis


                                                             c.        Neurotoxicity


                                                             d.        Hepatotoxicity and hepatitis;

                                                                increased liver function test levels

                                                             e.        Pyridoxine deficiency

                                                             f. Irritation at injection site with
                                                                intramuscular administration
                                                             g. Nausea and vomiting
                                                             h. Dry mouth
                                                             i. Dizziness
                                                             j. Hyperglycemia

                                                             k.        Vision changes


                                             4.        Interventions


                                                             a. Assess for hypersensitivity.
                                                             b. Assess for hepatic dysfunction.
                                                             c. Assess for sensitivity to nicotinic acid.
                                                             d. Monitor liver function test results.
                                                             e. Monitor for signs of hepatitis, such as
                                                                anorexia, nausea, vomiting, weakness,
                                                                fatigue, dark urine, or jaundice; if these
                                                                symptoms occur, withhold the
                                                                medication and notify the PHCP.



                                                         1628
   1623   1624   1625   1626   1627   1628   1629   1630   1631   1632   1633